AR Harmer

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• United States Food and Drug Administration14.5%
• Universidade Federal do Pará8.4%
• University College London6.9%
• Eisai (Japan)6.9%
• Centro de Estudios Científicos6.9%
• Boehringer Ingelheim (Germany)6.1%
• Other50.4%

Fields

• Medicine67.4%
• Pharmacology, Toxicology and Pharmaceutics9.3%
• Immunology and Microbiology4.7%
• Mathematics4.7%
• Neuroscience4.7%
• Biochemistry, Genetics and Molecular Biology2.3%
• Other7%

Topics

• Cardiac electrophysiology and arrhythmias28.7%
• Ion channel regulation and function12.6%
• Epilepsy research and treatment8%
• Neuroscience and Neuropharmacology Research5.7%
• Pharmacological Effects and Toxicity Studies5.7%
• Computational Drug Discovery Methods4.6%
• Other34.5%